Clearmind Medicine (CMND) vs Jupiter Neurosciences (JUNS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Jupiter Neurosciences is the larger company by market cap ($3.7 million vs $3.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CMND | JUNS |
|---|---|---|
| Share price | $6.60 | $2.77 |
| Market cap | $3.35M | $3.65M |
| 1-day change | 0.00% | -2.46% |
| Forward P/E | — | 46.17 |
| EPS (TTM) | $-461.20 | $-18.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3,840.00 | $135.75 |
| 52-week low | $5.25 | $2.25 |
| Distance from 52-week high | -99.83% | -97.96% |
| Average volume | 70.89K | 983.10K |
| Shares outstanding | 507.40K | 1.32M |
| Employees | — | 5 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Clearmind Medicine
CMND stock →Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression.
Healthcare · Biotechnology
About Jupiter Neurosciences
JUNS stock →Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements.
Healthcare · Biotechnology · 5 employees
CMND vs JUNS FAQ
Which is bigger, Clearmind Medicine or Jupiter Neurosciences?
Jupiter Neurosciences (JUNS) is larger, with a market capitalization of $3.65M compared with $3.35M for Clearmind Medicine (CMND).
Are Clearmind Medicine and Jupiter Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.